Literature DB >> 25918290

Durable Responses With PD-1 Inhibition in Lung and Kidney Cancer and the Ongoing Search for Predictive Biomarkers.

Mark M Awad1, Peter S Hammerman2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25918290     DOI: 10.1200/JCO.2015.61.4172

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  8 in total

1.  Immunotherapy for lung cancer.

Authors:  María González-Cao
Journal:  Transl Lung Cancer Res       Date:  2015-12

2.  A pilot study exploring the molecular architecture of the tumor microenvironment in human prostate cancer using laser capture microdissection and reverse phase protein microarray.

Authors:  Elisa Pin; Steven Stratton; Claudio Belluco; Lance Liotta; Ray Nagle; K Alex Hodge; Jianghong Deng; Ting Dong; Elisa Baldelli; Emanuel Petricoin; Mariaelena Pierobon
Journal:  Mol Oncol       Date:  2016-10-14       Impact factor: 6.603

Review 3.  Opportunities and challenges in combination gene cancer therapy.

Authors:  Kent L Nastiuk; John J Krolewski
Journal:  Adv Drug Deliv Rev       Date:  2015-12-23       Impact factor: 15.470

4.  Significance of Programmed Death Ligand 1 (PD-L1) Immunohistochemical Expression in Colorectal Cancer.

Authors:  Lisha Wang; Fei Ren; Qifeng Wang; Lee Ann Baldridge; M Francesca Monn; Kurt W Fisher; Weiqi Sheng; Xiaoyan Zhou; Xiang Du; Liang Cheng
Journal:  Mol Diagn Ther       Date:  2016-04       Impact factor: 4.074

5.  Comprehensive Genomic Characterization of Tumor Microenvironment and Relevant Signature in Clear Cell Renal Cell Carcinoma.

Authors:  Chuanjie Zhang; Feng Qi; Yuxiao Zheng; Xin Xia; Xiao Li; Xinwei Wang
Journal:  Front Oncol       Date:  2022-05-16       Impact factor: 5.738

6.  Prognostic impact of programed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor infiltrating lymphocytes in colorectal cancer.

Authors:  Yaqi Li; Lei Liang; Weixing Dai; Guoxiang Cai; Ye Xu; Xinxiang Li; Qingguo Li; Sanjun Cai
Journal:  Mol Cancer       Date:  2016-08-24       Impact factor: 27.401

7.  PD1 blockade enhances cytotoxicity of in vitro expanded natural killer cells towards myeloma cells.

Authors:  Yanan Guo; Xiaoli Feng; Yang Jiang; Xiaoyun Shi; Xiangling Xing; Xiaoli Liu; Nailin Li; Bengt Fadeel; Chengyun Zheng
Journal:  Oncotarget       Date:  2016-07-26

8.  Retrospective analysis of the prognostic value of PD-L1 expression and 18F-FDG PET/CT metabolic parameters in colorectal cancer.

Authors:  Hao Jiang; Rongjun Zhang; Huijie Jiang; Mingyu Zhang; Wei Guo; Jifeng Zhang; Xinglu Zhou; Wenbin Pan; Sheng Zhao; Ping Li
Journal:  J Cancer       Date:  2020-02-25       Impact factor: 4.207

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.